S-1/A: Volato Group Files Amendment No. 1 to Form S-1 Registration Statement for Stock and Warrants

Sentiment:

S-1/A Filing


Volato Group, Inc. has filed an amendment to its Form S-1 registration statement, covering the offer and sale of up to 8,092,122 shares of common stock, 15,226,000 warrants, and 15,226,000 shares of common stock issuable upon exercise of the warrants by selling stockholders.

Worse than expectedThe current stock price is significantly below the warrant exercise price, making warrant exercise unlikely.The sale of a large number of shares by selling stockholders could significantly decrease the stock price.

Summary

  • Volato Group, Inc. filed Amendment No. 1 to its Form S-1 registration statement on February 9, 2024.
  • The registration covers the offer and sale of up to 8,092,122 shares of common stock, 15,226,000 warrants, and 15,226,000 shares of common stock issuable upon exercise of the warrants.
  • These securities are to be offered and sold from time to time by the selling stockholders.
  • The shares of common stock being offered include shares converted from Class B shares, shares underlying private warrants, and shares issued to LSH Partners Securities LLC, Roth Capital Partners, LLC, and BTIG, LLC.
  • The private warrants were originally issued for $1.00 per warrant and entitle the holder to purchase one share of common stock at a price of $11.50 per share.
  • Volato Group will not receive any proceeds from the sale of these securities by the selling stockholders, except from the exercise of private warrants.
  • The company will pay the expenses associated with the sale of securities, excluding underwriting discounts or selling commissions incurred by the selling stockholders.
  • The common stock and warrants are listed on the NYSE American under the symbols SOAR and SOAR.WS, respectively.
  • As of February 1, 2024, the closing price of the common stock was $2.28 per share, and the closing price of the warrants was $0.15 per warrant.
  • The shares of common stock being offered represent approximately 52.4% of the shares outstanding as of February 1, 2024, assuming the issuance of all shares upon exercise of the private warrants.
  • The sale of these shares could result in a significant decline in the public trading price of the common stock.
  • The company believes the likelihood that warrant holders will exercise their warrants is dependent on the trading price of the common stock.
  • As of February 1, 2024, the closing price of the common stock was below the $11.50 exercise price of the warrants, and the company does not expect warrant holders to exercise their warrants while they remain out-of-the-money.
  • The company is an emerging growth company and is subject to certain reduced public company reporting requirements.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it outlines the offering of securities, it also highlights risks associated with the offering, such as potential price decline and the unlikelihood of warrant exercises. The low stock price relative to the warrant exercise price is a concern.

Negatives

  • The sale of a large number of shares by selling stockholders could significantly decrease the stock price.
  • Certain selling stockholders may experience a positive rate of return even if the market price is below $10.00, while public stockholders may not.
  • The current stock price is significantly below the warrant exercise price, making warrant exercise unlikely.
  • The company will not receive proceeds from the sale of these securities, except from the exercise of private warrants.

Risks

  • The sale of a substantial number of shares by selling stockholders could cause the market price of the common stock to decline.
  • The low trading price of the common stock relative to the warrant exercise price makes it unlikely that warrant holders will exercise their warrants.
  • The company's future liquidity may be limited as amounts to be received upon the exercise of Warrants was not factored into the Company's anticipated capital resources.
  • The terms of the Warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then outstanding Warrants approve of such amendment.

Future Outlook

The company believes the likelihood that warrant holders will exercise their warrants is dependent on the trading price of the common stock.

Industry Context

The document does not provide specific industry context beyond the company's own operations and financial condition.

Stakeholder Impact

  • Existing stockholders may experience dilution and a potential decline in the market price of the common stock.
  • Potential investors should carefully consider the risks associated with investing in the company's securities.
  • Warrant holders may find their warrants expire worthless if the common stock price does not increase above the exercise price.

Next Steps

  • The selling stockholders may offer and sell the securities from time to time.
  • Volato Group will use commercially reasonable efforts to maintain a current prospectus relating to the shares of common stock issuable upon exercise of the warrants until the warrants expire or are redeemed.

Key Dates

DateDescription
July 26, 2023Date of Letter Agreement with LSH Partners Securities LLC.
August 1, 2023Date of Business Combination Agreement.
October 16, 2023Date of Engagement Letter with Roth Capital Partners, LLC.
November 28, 2022Date of Letter Agreement with BTIG, LLC.
November 30, 2023Date of amendment to Letter Agreement with LSH Partners Securities LLC.
December 1, 2023Date of amendments to Engagement Letter with Roth Capital Partners, LLC and Letter Agreement with BTIG, LLC.
February 1, 2024Date of closing price of common stock ($2.28) and warrants ($0.15).
February 9, 2024Date of Amendment No. 1 to Form S-1 Registration Statement.

Keywords

common stock, warrants, selling stockholders, private warrants, Volato Group, registration statement, exercise price, shares, securities, offer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.